Filing Details
- Accession Number:
- 0000914190-13-000791
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-05 16:33:21
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2013-11-05
- Accepted Time:
- 2013-11-05 16:33:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180145 | Cardiovascular Systems Inc | CSII | Surgical & Medical Instruments & Apparatus (3841) | 411698056 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1428216 | J Robert Thatcher | 651 Campus Drive St. Paul MN 55112 | Executive Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-01 | 5,942 | $7.90 | 90,469 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-01 | 5,942 | $30.94 | 84,527 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-11-04 | 7,326 | $7.90 | 91,853 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-04 | 7,326 | $30.92 | 84,527 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-11-01 | 5,942 | $0.00 | 5,942 | $7.90 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-11-04 | 7,326 | $0.00 | 7,326 | $7.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,429 | 2017-08-06 | No | 4 | M | Direct | |
8,103 | 2017-08-06 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $12.37 | 2015-10-16 | 64,700 | 64,700 | Direct | |
Common Stock | Stock Option (right to buy) | $8.83 | 2016-12-18 | 7,764 | 7,764 | Direct | |
Common Stock | Stock Option (right to buy) | $8.83 | 2017-04-17 | 29,762 | 29,762 | Direct | |
Common Stock | Stock Option (right to buy) | $12.15 | 2017-12-11 | 32,350 | 32,350 | Direct | |
Common Stock | Stock Option (right to buy) | $8.75 | 2019-03-01 | 11,646 | 11,646 | Direct | |
Common Stock | Warrant | $8.83 | 2009-02-25 | 2014-02-24 | 3,045 | 3,045 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2015-10-16 | 64,700 | 64,700 | Direct |
2016-12-18 | 7,764 | 7,764 | Direct |
2017-04-17 | 29,762 | 29,762 | Direct |
2017-12-11 | 32,350 | 32,350 | Direct |
2019-03-01 | 11,646 | 11,646 | Direct |
2014-02-24 | 3,045 | 3,045 | Direct |
Footnotes
- The shares were sold pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $31.11 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.90 to $30.95 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Fully exercisable.